Seasonal influenza VLP vaccine: Additional Phase IIa data

Novavax Inc. (NASDAQ:NVAX), Rockville, Md. Product: Seasonal influenza VLP vaccine Business: Infectious Molecular target: Influenza antigen Description: Trivalent virus-like particle (VLP) vaccine aga...